Shahzad Ghanbarian

Bio

Dr. Shahzad Ghanbarian works at C2E2 as an experienced Mathematical Modeller and Health Economist. She informs decision-making in health policy science through her expertise in statistical modeling, particularly microsimulation and discrete event simulation. She earned a Ph.D. in Computational Biophysics focusing on atomistic simulations of DNA electrostatics. During her post-doctoral fellowship, she applied her analytical skills to health sciences, focusing on mathematical modeling of Chronic Obstructive Pulmonary Disease (COPD) and Osteoarthritis (OA). Since joining the C2E2 HTA team in 2017, Shahzad has worked on statistical modeling, cost-effectiveness evaluation, and budget impact analysis of different health technologies for the BC Ministry of Health. Currently, as a lead statistical modeler, Shahzad collaborates closely with Dr. Stirling Bryan and Dr. Jehannine Austin on a research project investigating the effectiveness and cost-effectiveness of pharmacogenomic testing to enhance antidepressant treatment for major depressive disorder (MDD). Additionally, Shahzad works alongside Dr. Stirling Bryan and Dr. Paul Keown to develop a discrete event simulation specifically focused on assessing the cost-effectiveness of genetic technologies such as eplet/molecular compatibility to enhance the matching of kidney donors and transplant recipients. Her research contributions have the potential to revolutionize treatment strategies, improve patient care, and optimize resource allocations within the healthcare system.